DURECT CORPORATION

ALZAID

ALZA AID;CHEMICAL COMPATIBILITY TEST KIT CONSISTING OF POLYMERS FOR ASSESSING AGENT AND SOLVENT COMPATIBILITY WITH OSMOTIC PUMPS;

ALZET

implantable and non-implantable pumps for use in dispensing fluids into small animals;

CHRONOCAINE

preparation for the relief of pain;

CHRONOGESIC

ISSUE NEW CERTIFICATE TO: DURECT CORPORATION (DELAWARE CORPORATION) 10240 BUBB ROAD CUPERTINO, CA 95014 BY ASSIGNMENT;Pharmaceuticals, namely analgesics;

CLOUD

Surgical, medical, and veterinary pharmaceutical preparations, namely, injectable and implantable drug delivery formulations used with various medications for controlled or sustained release of the medication; pharmaceutical preparations, namely, depot therapy drug formulations for use with a variety of medications; pharmaceutical and veterinary drug delivery formulations, namely, drug delivery agents consisting of compounds for use with a range of pharmaceutical preparations for controlled or sustained release of medication into the body; surgical, medical, and veterinary drug delivery systems in the form of depots for the delivery of drugs; excluding inhalers for medical purposes;

DUKEZO

pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders;The wording DUKEZO has no meaning in a foreign language.;

DURECT

In the statement, Column 1, line 1, CALIFORNIA should be deleted, and, DELAWARE should be inserted.;PRESCRIPTION PHARMACEUTICALS, NAMELY, PHARMACEUTICALS PRESCRIBED BY PHYSICIANS AND DELIVERED BY MEANS OF IMPLANTABLE DRUG DELIVERY DEVICES FOR THE TREATMENT OF CHRONIC DISEASES OF THE CENTRAL NERVOUS SYSTEM, [ CARDIO-VASCULAR DISEASE, OCCLUSIONS OF BLOOD VESSELS AND GRAFTS, ] [ EAR DISORDERS, ] [ CANCER, SPASTICITY, FAILED ] BACK PAIN, [ SPINAL CORD INJURIES, ] [ NEURO-DEGENERATIVE DISEASES, ] AND CHRONIC PAIN; AND DRUG DELIVERY DEVICES CONTAINING MEDICATIONS, NAMELY, IMPLANTABLE DEVICES FOR DELIVERY OF DRUGS BY IMPLANTATION AND RELEASE OF MEDICATIONS IN THE HUMAN BODY;

DURECT

[ Surgical, medical, dental, and veterinary instruments and apparatus, namely, speculum; products and instruments for the delivery of fluids to the ear and for the treatment of ear disorders, namely, ear catheters; ] implantable and non-implantable pumps sold without medication for use in dispensing fluids and medications into humans and animals; [ measuring devices, diagnostic devices, sizing devices and surgical insertion instruments used in connection with products and instruments for the delivery of fluids to the ear and for the treatment of ear disorders ];

DURECT

Research and development of pharmaceutical preparations and medical devices; research and development of biodegradable polymers for pharmaceutical and biotechnology companies;

DURECT

The mark consists of the stylized word durect with the letter 'e' having a gradient crossbar and with the letter 'd' in the form of an abstract DNA symbol with gradient effect.;Miniature fluid dispensers for experimental use in laboratory animals; implantable and non-implantable pumps for use in dispensing fluids and medications into animals for scientific use;Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, neurological diseases and disorders, central nervous system diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders;Color is not claimed as a feature of the mark.;Implantable and non-implantable pumps sold without medication for use in dispensing fluids and medications into animals;